UKHSA staff with symptoms of a respiratory infection guideline
Covering the management of healthcare staff with symptoms of a respiratory infection, including COVID-19 and positive COVID-19 test results
NHS point-of-care testing guideline
Covering NHS guidance on providing point-of-care testing services in community pharmacy, including equipment selection, service delivery, and governance
Let’s talk about weight guideline
Support your patients to manage their weight by initiating a conversation. This is a step-by-step guide to brief interventions with adults.
NICE tobacco guideline
A new single source for tobacco guidance from NICE, covering promoting quitting, and treating tobacco dependence and tobacco-dependent pregnant women
PHE influenza immunisation policy
This summary provides comprehensive guidance about flu immunisation for public health professionals
AWMSG prescribing guide
Guidance on solving prescribing dilemmas, including (but not limited to) clinical responsibility, prescribing duration, and complementary therapies
SCIE indicators of abuse guideline
This summary explores the forms that abuse can take, and the signs or possible indicators that may suggest a person is experiencing abuse
In practice: guidance for pharmacist prescribers
This guidance sets out the key areas pharmacist prescribers should consider when applying GPhC standards to their prescribing practice
PHE tobacco commissioning support
This useful summary of PHE guidance covers key points for primary care, effective commissioning, and supporting people to stop smoking
Let’s talk about weight in children guideline
This summary relates to families of 4–12-year-old children and young people, covering how to discuss weight, and support positive lifestyle changes.
Resource hub
Having a smear test—what is it about?
Supporting nurse mentors to reduce the barriers to implementing alcohol Interventions and Brief Advice (IBA) in primary care
- Previous
- Next
Educational resources
Liraglutide 6 mg/ml solution for injection in pre-filled pen (Saxenda®) SMC2455
Information intended for UK healthcare professionals only. The production of this Guidelines card has been commissioned by Novo Nordisk Limited.
View Saxenda® (liraglutide 3 mg) Great Britain and Northern Ireland prescribing information and adverse event reporting information.
UK22SX00249
Date of preparation: June 2022
Sixmo®▼ (buprenorphine) 74.2mg implant SMC2372
The production of this Guidelines card has been commissioned by Accord Healthcare Limited.
View adverse event reporting and prescribing information
UK-03735 April 2022
Management of obesity in primary care: a Guidelines algorithm
Information intended for UK healthcare professionals only. These videos have been funded through an arm’s-length sponsorship by Novo Nordisk Limited. Guidelines approached Novo Nordisk Limited to fund the production of these videos.
Date of preparation: December 2021
Managing obesity in primary care
This management algorithm was developed by a multidisciplinary expert panel: Tahrani et al with the support of an educational grant from Novo Nordisk Limited. Information intended for UK healthcare professionals.